We provide you with 20 years of free, institutional-grade data for CFRX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CFRX. Explore the full financial landscape of CFRX stock.
| Reported Date | CIK | Ticker | Type |
|---|
ContraFect Corporation(NASDAQ:CFRX) 
ContraFect Corporation, a clinical-stage biotechnology company, focuses on the discovery and development of therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead product candidates consist of CF-301, an i...
Website: http://www.contrafect.com
Founded: 2008
Full Time Employees: 24
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about CFRX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.